“…The XDK 2− ligand also supports carboxylate-bridged diiron(II) units having the general composition [Fe II 2 (XDK)(μ-RCO 2 )(RCO 2 )( N -donor) 2 ], where R = t -Bu- (pivalate), PhCy- (1-phenylcyclohexylcarboxylate), Ph- (benzoate), i Pr- (isobutyrate), or t BuCH 2 - (1- tert -butylacetate); N -donor = py (pyridine), 3-Fpy (3-fluoropyridine), N -MeIm ( N -methylimidazole), or N - t BuIm ( N - tert -butylimidazole) [54–56]. More sterically hindered XDK 2− variants, containing either propyl (PXDK 2− ) or benzyl (BXDK 2− )in place of methyl substituents on the Kemp’s triacid moiety, could also be employed to assemble similar diiron(II) compounds.…”